For the latest openings visit the Careers section of our website CPL Biologicals launches Cadiflu-S,World`s First Virus Like Particle(VLP) Vaccine for Seasonal Influenza
The public at large is cautioned of fraudulent activities and false commitments using the name of Cadila.

News & Events

  • CPL Biologicals launches Cadiflu-S, World’s First Virus Like Particle (VLP) Vaccine for Seasonal Influenza Read More >>
Get a Quote
Pranlukast Manufacturer

We are industry leader in synthesizing APIs. We are bulk manufacturer of Asthma drug Pranlukast. The CAS number of Pranlukast is 103177-37-3.

Pranlukast is a leukotriene inhibitor drug. It is very effective in treating Asthma.
Cadila Pharmaceuticals Limited is a USFDA approved major pharma company based in India. It’s Active Pharmaceutical Ingredients (APIs) plant is approved by USFDA. Cadila Pharmaceuticals is one of the FDA approved API manufacturer. One of the core expertises of our company is to synthesize Active Pharmaceutical Ingredients (APIs) of the top notch quality in affordable manner.

Cadila Pharmaceuticals Ltd. is a pioneer pharma company in synthesizing APIs. We are market leader in Pranlukast manufacturing and supplying. We supply Pranlukast domestically and also to country like Japan.

Counterfeit Drugs: In case of any information on /or availability of counterfeit products... Read More © 2019 Cadila Pharmaceuticals all right reserved
Corporate identification No : U24231GJ1991PLC015132
Cadila Pharmaceuticals